<% (signals.list.current.rate).substr(0,7) %>
<% signal.analyst %>
<% signal.analyst %>
Last Updated: Feb 23, 2026 04:34:36 PM (GMT)
ZBH: The current market price is 98.60, reflecting a 0.6% increase from the previous close.
Support and Resistance Levels The current support levels are at 97.50, 97.00, and 96.50. Resistance levels are at 99.00, 99.50, and 100.00, with a pivot point at 98.25.
Indicators The RSI is at 72.6, indicating overbought conditions. The ATR is 0.335, suggesting lower volatility. The ADX is 84.20, showing a strong trend. The 50-day SMA is 98.60 and the 200-day EMA is 98.05. The Parabolic SAR indicates upward momentum at 98.20.
Market Sentiment The market is bullish since the price is above the pivot point (98.25), supported by indicators indicating a strong buying trend.
ZBH Signals & Technical Analysis
Market Sentiment
Trend Indicators
Oscillators
Moving Averages
Pivot
About (zbh) Zimmer Biomet Holdings, Inc.
Company Background
Zimmer Biomet Holdings, Inc. (NYSE: ZBH), headquartered in Warsaw, Indiana, is a global leader in musculoskeletal healthcare. Founded in 1927, the company specializes in the design, manufacturing, and marketing of orthopedic reconstructive products, including knee and hip implants, spine products, and dental solutions. Zimmer Biomet is dedicated to enhancing the quality of life for patients suffering from musculoskeletal conditions, utilizing advanced technologies and innovative solutions to meet diverse patient needs.
Market Position
As one of the top competitors in the orthopedic device industry, Zimmer Biomet holds a significant market share alongside rivals such as Stryker Corporation and Johnson & Johnson. The company operates in over 100 countries, employing a strong distribution network and leveraging strategic partnerships to reach healthcare professionals and institutions effectively. Zimmer Biomet's robust portfolio includes a wide array of products tailored for both surgical and non-surgical treatment options, solidifying its standing in the rapidly evolving healthcare environment.
Key Financial Highlights
Zimmer Biomet has exhibited strong financial performance in recent years, driven by the growing demand for orthopedic solutions. The company's revenues for the latest fiscal year surpassed $7 billion, with a consistent year-over-year growth rate attributed to innovative product launches and strategic acquisitions. The company's commitment to research and development has resulted in an impressive pipeline of new technologies aimed at improving surgical outcomes and patient recovery times. Furthermore, Zimmer Biomet maintains a healthy balance sheet with a solid cash flow, enabling continued investment in expansion and innovation.
Industry Highlights
The orthopedic device market is projected to reach approximately $64 billion by 2027, driven by factors such as an aging population, increased prevalence of orthopedic disorders, and advancements in surgical techniques. Zimmer Biomet is well-positioned to capitalize on these trends, with its focus on minimally invasive procedures and enhanced recovery solutions. As the company continues to innovate and expand its global footprint, it aims to maintain its leadership role in the orthopedic sector, ensuring improved patient outcomes and sustained growth.
Related Stocks
Sidebar rates
- <% signal.pair %>
<% signals.active.Current.rate.substr(0,7) %>
